Aranda Pharma is a preclinical stage pharmaceutical
company. We are developing novel non-steroidal small molecule inhibitors of the androgen receptor,
that are advanced as locally acting anti-androgens for the topical
treatment of acne.
Events
Aranda Pharma organized an investor webinar on December 21st. The webinar recording can be viewed above or from link below.
in English:
https://www.youtube.com/watch?v=QxPdV27u0is
in Finnish:
2021-12-21
Aranda Pharma is hosting an investor webinar on Tuesday, 21 December at 6 pm EET.
Register here
https://www.enchant.fi/arandapharma/investor-webinar
Aranda Pharma järjestää sijoittajille webinaarin tiistaina 21.12. klo 17.
Ilmoittaudu tästä
2021 - December
We are fundraising. The round is open until December 30, 2021. https://invest.invesdor.com/en/pitches/1102
2021-02-11
Aranda Pharma Ltd received a grant from the Centre for Economic Development, Transport and the Environment (ELY Centre). The grant will be used to strengthen and explore international business potential of company’s ADA-308 program.
